Among GLP-1RAs with notable neuroprotective potential, NLY01, a PEGylated form of exendin-4, has emerged as a long-acting agent
Researchers are currently focusing on the molecular and cellular mechanisms underlying AD and PD, which are key to targeted therapies
Signs That B12 Treatment Is Working Recognising the signs of treatment response helps patients and clinicians assess whether B12 therapy is effective
(II) Suicide risk would be the same or lower after treatment with GLP-1 RAs compared with the period before treatment
HbA 1c was reduced in SURPASS 15, using from 5 to 15 mg of TZP per week, by between 1.69 to 2.58%, and a new plateau of HbA 1c and fasting serum glucose (FSG) was reached with approximately 2430 weeks of treatment
Research shows that between 3050% of commercially traded milk thistle products do not meet their labelling claim for silymarin content (21)